Biotech · Private company
Frantz Viral Therapeutics, LLC
Track this companyFree. Adds Frantz Viral Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials54 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ArtesunatePhase 2 · Anal High Grade Squamous Intraepithelial LesionClinicalTrials.gov · fetched Nov 12, 2026
- Artesunate ointmentPhase 2 · Anal High-grade Squamous Intraepithelial LesionClinicalTrials.gov · fetched Nov 12, 2026
- Artesunate ointmentPhase 2 · Vulvar DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Artesunate vaginal insertPhase 2 · CIN 2/3ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsPHASE2 · RECRUITING · started Jan 12, 2024ClinicalTrials.gov NCT06206564 · fetched Nov 12, 2026
- Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)PHASE2 · RECRUITING · started Dec 6, 2023ClinicalTrials.gov NCT06075264 · fetched Nov 12, 2026
- Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSILPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 10, 2023ClinicalTrials.gov NCT05555862 · fetched Nov 12, 2026
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)PHASE2 · RECRUITING · started Sep 9, 2020ClinicalTrials.gov NCT04098744 · fetched Nov 12, 2026
- Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)PHASE1 · COMPLETED · started Apr 17, 2019ClinicalTrials.gov NCT03792516 · fetched Nov 12, 2026